(S (NP-SBJ Reticuloendotheliosis/NN virus/NN long/JJ terminal/JJ repeat/NN elements/NNS) (VP are/VBP (NP-PRD (NP efficient/JJ promoters/NNS) (PP in/IN (NP (NP cells/NNS) (PP of/IN (NP (NP various/JJ (NP-COOD (NP species/NNS) and/CC (NP tissue/NN))) origin/NN)) ,/, (PP including/VBG (NP human/JJ lymphoid/JJ cells/NNS)))))) ./.)
(S (S (S (NP-SBJ-9 (NP Promiscuous/JJ transcriptional/JJ activity/NN) (PP of/IN (NP (NP (NP the/DT reticuloendotheliosis/NN virus/NN) (PRN -LRB-/-LRB- (NP REV/NN) -RRB-/-RRB-)) (NP (NP long/JJ terminal/JJ repeat/NN) (PRN -LRB-/-LRB- (NP LTR/NN) -RRB-/-RRB-))))) (VP was/VBD (VP detected/VBN (NP *-9/-NONE-) (PP in/IN (NP transient/JJ expression/NN assays/NNS)) (S (NP-SBJ */-NONE-) (VP using/VBG (NP-COOD (NP LTR-chloramphenicol/NN acetyltransferase-encoding/JJ gene/NN chimeras/NNS) ,/, and/CC (NP (NP cells/NNS) (PP of/IN (NP (NP diverse/JJ (NP-COOD (NP species/NNS) and/CC (NP tissue/NN))) type/NN)))))))) ;/:) (S (NP-SBJ (NP levels/NNS) (PP of/IN (NP (NP expression/NN) (PP from/IN (NP two/CD different/JJ REV/NN LTRs/NNS))))) (VP correlate/VBP (PP with/IN (NP (NP reports/NNS) (PP of/IN (NP (NP pathogenicity/NN) (PP of/IN (NP the/DT respective/JJ viruses/NNS)) (ADVP in/FW vivo/FW)))))) ./.)))
(S-COOD (S (NP-SBJ REVs/NNS) (VP do/VBP not/RB (VP encode/VB (NP (NP a/DT transactivator/NN) (VP targeted/VBN (NP */-NONE-) (PP to/TO (NP the/DT viral/JJ LTR/NN))))))) ,/, and/CC (S (NP-SBJ (NP cells/NNS) (VP infected/VBN (NP */-NONE-) (PP with/IN (NP (NP (NP Marek/NN 's/POS) disease/NN virus/NN) ,/, (NP (NP a/DT herpesvirus/NN) (PP with/IN (NP an/DT overlapping/VBG host/NN range/NN))) ,/,)))) (VP do/VBP not/RB (VP express/VB (NP (NP factors/NNS) (SBAR (WHNP-10 that/WDT) (S (NP-SBJ *T*-10/-NONE-) (ADVP preferentially/RB) (VP enhance/VBP (NP (NP expression/NN) (PP from/IN (NP-COOD (NP REV/NN) or/CC (NP avian/JJ sarcoma\/leukemia/NN virus/NN LTRs/NNS))))))))))) ./.)
(S (NP-SBJ REV/NN LTRs/NNS) (VP-COOD (VP work/VBP (ADVP efficiently/RB) (PP in/IN (NP human/JJ lymphoid/JJ cells/NNS))) ,/, and/CC (VP are/VBP (NP-PRD (NP viable/JJ alternatives/NNS) (PP to/TO (NP (NP promoters/NNS) (VP (ADVP commonly/RB) used/VBN (NP */-NONE-) (PP for/IN (NP (NP expression/NN) (PP of/IN (NP cloned/VBN genes/NNS)))))))))) ./.)
(S (NP-SBJ They/PRP) (VP may/MD (ADVP also/RB) (VP prove/VB (ADJP-PRD useful/JJ) (PP in/IN (NP (NP the/DT identification/NN) (PP of/IN (NP (ADJP-COOD (ADJP new/JJ) ,/, (ADJP ubiquitous/JJ)) cellular/JJ transcription/NN factors/NNS)))))) ./.)
